MS patients had higher serum levels of BNP (630.78 ± 50.25 vs. 487.01 ± 42.47 mmol/l, p-value 0.001), ST2 protein (134.12 ± 5.7 vs. 82 ± 7.85 ng/ml, p-value 0.001), and CRP (9. Here, NPPB is linked to myeloid sarcoma.